Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Science Immunology(2021)10.1126/sciimmunol.abl4340Source: DataRank Database

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths is a research paper published in Science Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 634 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access634 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 33.26)OA: hybridTopics (56)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (100)

Adrian Gervais ORCID,Tom Le Voyer ORCID,Jérémie Rosain ORCID,Quentin Philippot ORCID,Jérémy Manry ORCID

Live enrichment

PubMed:34413139 PMC:PMC8521484 OpenAlex:https://openalex.org/W3195130348

NIAID NIH HHS

Grant: R01 AI163029

Medical Research Council

Grant: MR/S032304/1

NCATS NIH HHS

Grant: UL1 TR001866

Intramural NIH HHS

Grant: ZIA AI001270

Novo Nordisk Fonden

Grant: NNF20OC0059288

NIAID NIH HHS

Grant: U19 AI111825

NIH HHS

Grant: 2U19 AI111825

NHGRI NIH HHS

Grant: UM1 HG006504

Novo Nordisk Fonden

Grant: NNF20OC0064890

NIH HHS

Grant: S10 OD018521

NIAID NIH HHS

Grant: R01 AI091707

NCI NIH HHS

Grant: 75N91019D00024

NIAID NIH HHS

Grant: R01 AI088364

NIH HHS

Grant: R01 AI091707-10S1

NHGRI NIH HHS

Grant: U24 HG008956

Intramural NIH HHS

Grant: ZIA AI001265

Intramural NIH HHS

Grant: 1ZIA AI001265

NIH HHS

Grant: P01 AI138398-S1

Howard Hughes Medical Institute

FWCI

33.26

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1126/sciimmunol.abl4340

publisherhttps://doi.org/10.1126/sciimmunol.abl4340

publisherhttps://www.science.org/doi/pdf/10.1126/sciimmunol.abl4340

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34413139

repositoryhttps://iris.unil.ch/handle/iris/33874

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDiabetes and associated disordersAdolescentAdultAgedAged, 80 and overAntibodies, NeutralizingAutoantibodiesCOVID-19Case-Control StudiesChildChild, PreschoolCritical IllnessHumansImmunoglobulin GInfantInfant, NewbornInterferon Type IInterferon-alphaMiddle AgedYoung Adult

MeSH Terms

COVID-19AdolescentAdultAgedAged, 80 and overAutoantibodiesChildChild, PreschoolHumansImmunoglobulin GInfantInfant, NewbornInterferon Type IMiddle AgedCase-Control StudiesCritical IllnessInterferon-alphaYoung AdultAntibodies, Neutralizing

Keywords

AutoantibodyCoronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCoronavirus InfectionsNeutralizing antibodyBiologyAntibodyMedicineDiseaseOutbreakInternal medicineInfectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being